Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
C
600511
vs
S
Shanghai Composite
Over the past 12 months, China National Medicines Corp Ltd has underperformed Shanghai Composite, delivering a return of -8% compared to Shanghai Composite's 7% drop.
Stocks Performance
600511 vs Shanghai Composite
Performance Gap
600511 vs Shanghai Composite
Performance By Year
600511 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
China National Medicines Corp Ltd
Glance View
China National Medicines Corp Ltd is a Chinese healthcare company that sits in the middle of the drug supply chain. It buys prescription medicines, over-the-counter drugs, medical devices, and related health products from manufacturers and sells them onward to hospitals, pharmacies, clinics, and other healthcare buyers. It also helps move and store these products through its distribution and logistics network. The company makes money mainly by acting as a wholesaler and retailer. In wholesale, it earns a spread between what it pays manufacturers and what it charges healthcare customers. In retail and related services, it sells products through pharmacy channels and may charge for delivery, inventory management, and other supply-chain services tied to medical procurement. What makes its business important is that it is not a drug maker; it is a distributor and channel partner. That means it helps connect pharmaceutical producers with the institutions and patients that need the products, while handling purchasing, warehousing, cold-chain transport, and delivery. For beginner investors, the key idea is that the company’s role is to keep medicines and medical products moving through China’s healthcare system.